NATICK, Mass., Sept. 3, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2013 Morgan Stanley Global Healthcare Conference on Sept. 9 in New York.

Mike Mahoney, president and chief executive officer, and Jeff Capello, executive vice president and chief financial officer, will participate in a 30-minute question and answer session regarding the company beginning at approximately 11:45 a.m. ET.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A live webcast of the session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at bostonscientific.com/investors. 

This webcast is being hosted by Morgan Stanley.  A replay will be archived and available at bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:  

Peter Lucht
508-650-8796 (office)
Global Media Relations
Boston Scientific Corporation
media@bsci.com

Michael Campbell
508-650-8023 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

SOURCE Boston Scientific Corporation